Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Immunity|October 7, 2008
Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel blockMelanie P Matheu, Christine Beeton, Adriana Garcia, et al.
Elife|December 28, 2022
Computational design of peptides to target Na<sub>V</sub>1.7 channel with high potency and selectivity for the treatment of painPhuong T Nguyen, Hai M Nguyen, Karen M Wagner, et al.
Scientific Reports|January 4, 2017
Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitorM Flinspach, Q Xu, A D Piekarz, et al.
Molecular Pharmacology|January 6, 2009
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytesM W Pennington, C Beeton, C A Galea, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 29, 2012
Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune diseaseEric J Tarcha, Victor Chi, Ernesto J Muñoz-Elías, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 4, 2014
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesSandeep Chhabra, Shih Chieh Chang, Hai M Nguyen, et al.
The Western Journal of Emergency Medicine|June 15, 2017
Efficacy and Safety of Tranexamic Acid in Prehospital Traumatic Hemorrhagic Shock: Outcomes of the Cal-PAT StudyMichael M Neeki, Fanglong Dong, Jake Toy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 17, 2018
Utility and limitations of exome sequencing as a genetic diagnostic tool for children with hearing lossSarah Sheppard, Sawona Biswas, Mindy H Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesChristine Beeton, Heike Wulff, Nathan E Standifer, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Modulation of Lymphocyte Potassium Channel K<sub>V</sub>1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant DefensinSeow Theng Ong, Saumya Bajaj, Mark R Tanner, et al.
Pageof 16